Phase II trial of cisplatin plus temozolomide, in recurrent and progressive malignant glioma patients.
about
Dose finding and O6-alkylguanine-DNA alkyltransferase study of cisplatin combined with temozolomide in paediatric solid malignancies.Phase II trial of low-dose continuous (metronomic) treatment of temozolomide for recurrent glioblastoma.A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma.Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas.Temozolomide in malignant gliomaCanadian recommendations for the treatment of recurrent or progressive glioblastoma multiformeThe future of high-grade glioma: Where we are and where are we going.Therapy for recurrent malignant glioma in adults.Treatment of adults with recurrent malignant glioma.Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo.Selection of chemotherapy for glioblastoma expressing O(6)-methylguanine-DNA methyltransferaseCytotoxic and molecular chemotherapy for high-grade glioma: an emerging strategy for the future.Standards of care for treatment of recurrent glioblastoma--are we there yet?New developments in the treatment of malignant gliomas.Continuous dose-intense temozolomide and cisplatin in recurrent glioblastoma patientsA phase II single-arm study of irinotecan in combination with temozolomide (TEMIRI) in children with newly diagnosed high grade glioma: a joint ITCC and SIOPE-brain tumour study.The role of cytotoxic chemotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.Let-7b expression determines response to chemotherapy through the regulation of cyclin D1 in glioblastomaFractionated stereotactic reirradiation and concurrent temozolomide in patients with recurrent glioblastoma.Characterization of 2,3,6,7,10,11-hexahydroxytriphenylene and its effects on cell viability in human cancer cell lines.A drug combination targeting hypoxia induced chemoresistance and stemness in glioma cells.
P2860
Q33368246-4069DF4A-39DB-4E9B-AE3B-93D1CBA17B88Q33388306-1BB8F730-9C6F-496C-AC61-753100F2C4DDQ33391296-D63AB4A9-40B4-4296-80DA-D0320045F2DAQ33973844-82760B06-9B0B-47A1-B720-144EC05CC51BQ34623633-957C3795-56CC-404C-95B1-0FFDCBECF59BQ35027024-8E3BF04B-DF56-4532-B14A-04F685761698Q35114090-EAC6CF9E-9D91-4F05-A1FE-B887FF10915FQ35918439-ED361669-A874-424B-BFEF-4A215D6807BFQ36198612-A27FF016-46E4-483C-8780-E57DC74C3AEBQ36291188-E3FDA505-17CC-4914-B6CA-A467B261D72FQ36375392-7E4FC044-06EF-4144-B91D-36C17E5C17A1Q36429731-71D6087C-1201-41C2-A657-46F32D47BEE4Q36500401-01DCE8BC-7961-4B87-A03D-1E9979EFFEC6Q36972696-BB0841D8-C405-4BFA-92C5-3E9A45A52C90Q37696867-3EA32BB3-6841-4E1C-9A57-03BA4F035671Q38086448-F83CC81C-2EAA-4656-B121-CEDB05F3109FQ38205133-417EA347-E19B-4206-B510-0E825A279CA2Q39134240-77A793F1-D5A6-4F81-BA06-A5971822EDCCQ39820294-C5F81DBB-C65E-4B4C-B42A-F087DBFE66C4Q46581442-7F4D973B-7EC5-42F5-9823-2F865C0D7A6BQ55012542-5DF12CE5-C7CB-4558-A305-F6E7ADBEC908
P2860
Phase II trial of cisplatin plus temozolomide, in recurrent and progressive malignant glioma patients.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Phase II trial of cisplatin pl ...... ive malignant glioma patients.
@ast
Phase II trial of cisplatin pl ...... ive malignant glioma patients.
@en
type
label
Phase II trial of cisplatin pl ...... ive malignant glioma patients.
@ast
Phase II trial of cisplatin pl ...... ive malignant glioma patients.
@en
prefLabel
Phase II trial of cisplatin pl ...... ive malignant glioma patients.
@ast
Phase II trial of cisplatin pl ...... ive malignant glioma patients.
@en
P2093
P1476
Phase II trial of cisplatin pl ...... ive malignant glioma patients.
@en
P2093
Amerigo Boiardi
Andrea Salmaggi
Antonio Silvani
Elena Lamperti
Elio Maccagnano
Giovanni Broggi
Marica Eoli
P304
P356
10.1023/B:NEON.0000013479.64348.69
P577
2004-01-01T00:00:00Z
P6179
1003703509